Fusion event
HBV-TNNT3 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
1945407/1924177 (Hg38)
Nearest miRNA
hsa-mir-210/Upstream/44030; hsa-let-7a-2/Downstream/72582;
Upstream sequence
ctgtctctgtatctttcagcctcttggtctctgtctctccctgcctctctctctcagtctctgtctttcttggcctctctgtccccatttctccacctcc
Downstream sequence
atctccatctctgtctctctgtgtctccatccctCCATGCCACCCCCCAACCCTGTGCTGTAACCCTGGGTGGAGCCTGGAGCCCCCTCCCTGTGCTGGC
Target sequence
GTAAAGTTTACTTTTACTTACATTAACTTAGAATCTTGAACAAATTTATTGTAGTAGTTCTTTAAATAGGAATTGTGTGGGGCTGTCAGATTTCTGTTACGTTGGCGACCAGGGTGGGGAATTTGCTCTATTTGCAGAAGCCAATCTGAGAGCTTATAGTTCTTGAGTTAAAACTGCTGGTTTCACTACAACACTATTGCTGAAAAATTTAGTAGTTTATTGGTTTCTTCTGCACTT
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.